Intriguingly, the obtained results from our in vitro and ex vivo validation were in concordance with other studies that reported TINAGL1 as a Sec23a-dependent metastasis suppressor being upregulated in metastatic tumors [44]. The gene discussed is SEC23A; the disease is metastatic neoplasm.